These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 21492253)

  • 1. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
    Iannitti T; Palmieri B; Aspiro A; Di Cerbo A
    Drug Des Devel Ther; 2014; 8():931-5. PubMed ID: 25075176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous regional anesthesia (Bier's block) for botulinum toxin therapy of palmar hyperhidrosis is safe and effective.
    Blaheta HJ; Vollert B; Zuder D; Rassner G
    Dermatol Surg; 2002 Aug; 28(8):666-71; discussion 671-2. PubMed ID: 12174055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What stands in the way of treating palmar hyperhidrosis as effectively as axillary hyperhidrosis with botulinum toxin type A.
    Benohanian A
    Dermatol Online J; 2009 Apr; 15(4):12. PubMed ID: 19450405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
    Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K
    Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study.
    Wu CJ; Chang CK; Wang CY; Liao YS; Chen SG
    Dermatol Surg; 2019 Dec; 45(12):1605-1609. PubMed ID: 30829777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
    Glogau RG
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome.
    Gottsch HP; Miller JL; Yang CC; Berger RE
    Neurourol Urodyn; 2011 Jan; 30(1):93-6. PubMed ID: 20589903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
    Ibrahim O; Kakar R; Bolotin D; Nodzenski M; Disphanurat W; Pace N; Becker L; West DP; Poon E; Veledar E; Alam M
    J Am Acad Dermatol; 2013 Jul; 69(1):88-95. PubMed ID: 23591103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.
    Glaser DA
    J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.